Charles B. Shoemaker
17Patents
5h-index
15Co-inventors
63Inventor score
Filing activity: May 5, 1986 → Jul 9, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4835260A | Erythropoietin composition | Emerging Cross-Sectional Technologies | 72 | Expired |
| US4770999A | High yield production of active Factor IX | Chemistry; Metallurgy | 44 | Expired |
| US9023352B2 | Methods, compositions and kits for treating a subject using a recombinant heteromultimeric neutralizing binding protein | Emerging Cross-Sectional Technologies | 15 | Active |
| US8349326B2 | Methods and systems for multi-antibody therapies | Emerging Cross-Sectional Technologies | 9 | Active |
| US9834616B2 | Methods, compositions and kits for treating a subject using a recombinant heteromultimeric neutralizing binding protein | Emerging Cross-Sectional Technologies | 9 | Active |
| US8865169B2 | Methods and systems for multi-antibody therapies | Emerging Cross-Sectional Technologies | 5 | Active |
| US5763271A | Vasodilatory and immune suppressant peptides | Human Necessities | 5 | Expired |
| US8492109B2 | Methods for the delivery of toxins or enzymatically active portions thereof | Physics | 5 | Active |
| US10202441B2 | Methods, compositions and kits for treating a subject using a recombinant neutralizing binding protein | Chemistry; Metallurgy | 5 | Active |
| US10766950B2 | Methods, compositions and kits for treating a subject using a recombinant neutralizing binding protein | Chemistry; Metallurgy | 4 | Active |
| US11001625B2 | VHH based binding antibodies for anthrax and botulinum toxins and methods of making and using therefor | Physics | 3 | Active |
| US11091563B2 | Methods, compositions and kits for treating a subject using a recombinant heteromultimeric neutralizing binding protein | Emerging Cross-Sectional Technologies | 3 | Active |
| US12065486B2 | VHH based binding antibodies for anthrax and botulinum toxins and methods of making and using therefor | Physics | 0 | Active |
| US7326774B2 | Monoclonal antibody and nematode larval antigens | Human Necessities | 0 | Expired |
| US7294477B2 | Allergen and treatment | Human Necessities | 0 | Expired |
| US12077576B2 | VHH polypeptides that bind to Clostridium difficile toxin b and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US12084519B2 | Methods, compositions and kits for treating a subject using a recombinant heteromultimeric neutralizing binding protein | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.